Blog
-
Join the Alliance Now
Ashwagandha has become one of the most widely used botanical ingredients in global health and wellness. But growth has exposed some problems, and the public…
-
Supplyside Supplement Journal: ASA sets sights on ashwagandha standards and education
Thank you to Devon Gholam, Ph.D. and SupplySide Supplement Journal for covering the Ashwagandha Standards Alliance. One line in the article captures the problem well:…
-
New Infographic: Ashwagandha Facts, Not Fear
A Science-Based Guide to Safety, Quality and Labeling for Industry The Ashwagandha Standards Alliance has released a new educational infographic, Ashwagandha Facts, Not Fear, to help…
-
ASA Member Commentary on May 18 Article in Nutraceuticals World
I appreciate Monday’s ashwagandha article in Nutraceuticals World for the wide range of opinions expressed. This article correctly identifies one central scientific issue: that root,…
-
High Court stays FSSAI advisory banning ashwagandha leaves in supplements
The Karnataka High Court issued an interim stay on enforcement of FSSAI advisory seeking to ban the sale of ashwagandha leaf in India.
-
Technical Review Paper Drafted on Ashwagandha Safety, Withanolides and Analytical Standards
The Ashwagandha Standards Alliance has drafted a technical review in internal peer review prior to submission for publication. Ashwagandha (Withania somnifera (L.) Dunal) is among the…
-
Why Science-Based Standards Matter for Ashwagandha Ingredients
The Ashwagandha Standards Alliance promotes science-based education, quality, safety, and analytical harmonization for ashwagandha ingredients. In this post, we explain why standards matter and how…
-
Leaf Ban Hurts Small Farmers the Most
May 5, 2026 Why does agricultural policy tend to ignore the farmers? We see the impact now in real-time, in India. The recent ashwagandha leaf…
-
Technical Rebuttal to Recent Claims Regarding Ashwagandha Leaf
Technical Rebuttal to Recent Claims Regarding Ashwagandha Leaf, “Adulteration,” Method Validity, and the April 2026 Indian Regulatory Actions is a technical position report addressing recent regulatory…
-
Review of Ashwagandha: An umbrella review of the efficacy evidence
Ashwagandha: An Umbrella Review of the Efficacy Evidence by Brendler and Rattray (preprint, 2026) provides a comprehensive evaluation of the human clinical evidence for Withania somnifera across the…